These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8783630)

  • 1. Cyclooxygenase 2 induction: molecular mechanism and pathophysiologic roles.
    Wu KK
    J Lab Clin Med; 1996 Sep; 128(3):242-5. PubMed ID: 8783630
    [No Abstract]   [Full Text] [Related]  

  • 2. The discovery and function of COX-2.
    Needleman P; Isakson PC
    J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
    [No Abstract]   [Full Text] [Related]  

  • 3. COX-1 and COX-2 inhibition: current status and future perspective.
    Greyn J; Lauwers MH; Vanlersberghe C; Camu F
    Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
    [No Abstract]   [Full Text] [Related]  

  • 4. Prime suspect.
    Manuel J
    Environ Health Perspect; 1997 Jan; 105(1):28-9. PubMed ID: 9074875
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors.
    Szczeklik A; Sanak M
    Clin Exp Allergy; 2002 Mar; 32(3):339-42. PubMed ID: 11940059
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective cyclooxygenase-2 inhibitors as potential therapeutic agents for inflammatory diseases.
    Chan CC; Rodger IW
    Adv Exp Med Biol; 1997; 407():157-61. PubMed ID: 9321947
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostaglandin endoperoxide H synthases-1 and -2.
    Smith WL; Dewitt DL
    Adv Immunol; 1996; 62():167-215. PubMed ID: 8781269
    [No Abstract]   [Full Text] [Related]  

  • 8. [COX-2 expression in gastric cancers].
    Sakamoto C
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():598-603. PubMed ID: 11424449
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclooxygenase-2 inhibitors in cancer prevention and treatment.
    Masferrer JL
    Adv Exp Med Biol; 2003; 532():209-13. PubMed ID: 12908559
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclooxygenase-2 and skin carcinogenesis.
    Fürstenberger G; Marks F; Müller-Decker K
    Prog Exp Tumor Res; 2003; 37():72-89. PubMed ID: 12795049
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective inhibition of cyclooxygenase-2 attenuates expression of inflammation-related genes in CNS injury.
    O'Banion MK; Kyrkanides S; Olschowka JA
    Adv Exp Med Biol; 2002; 507():155-60. PubMed ID: 12664579
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclooxygenase-2 inhibitors.
    Nies AS; Gresser MJ
    Adv Protein Chem; 2001; 56():115-41. PubMed ID: 11329851
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress in the study of cyclooxygenase].
    Zhu H; Yang ZM
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):81-3. PubMed ID: 15127608
    [No Abstract]   [Full Text] [Related]  

  • 14. Introduction: mechanism of action of NSAIDs.
    Vane JR
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():1-3. PubMed ID: 8630629
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines.
    Tsuji S; Kawano S; Sawaoka H; Takei Y; Kobayashi I; Nagano K; Fusamoto H; Kamada T
    Prostaglandins Leukot Essent Fatty Acids; 1996 Sep; 55(3):179-83. PubMed ID: 8931116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.
    Whittle BJ
    Gut; 2000 Sep; 47(3):320-5. PubMed ID: 10940262
    [No Abstract]   [Full Text] [Related]  

  • 17. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2.
    Brooks P; Emery P; Evans JF; Fenner H; Hawkey CJ; Patrono C; Smolen J; Breedveld F; Day R; Dougados M; Ehrich EW; Gijon-Baños J; Kvien TK; Van Rijswijk MH; Warner T; Zeidler H
    Rheumatology (Oxford); 1999 Aug; 38(8):779-88. PubMed ID: 10501435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 inhibitors and atherosclerosis.
    Belton O; Fitzgerald D
    J Am Coll Cardiol; 2003 May; 41(10):1820-2. PubMed ID: 12767670
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible role of cyclooxygenase-2 in the brain vasculature in febrile response.
    Matsumura K; Cao C; Watanabe Y
    Ann N Y Acad Sci; 1997 Mar; 813():302-6. PubMed ID: 9100897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and clinical action of COX-2 selective NSAIDs.
    Bovill JG
    Adv Exp Med Biol; 2003; 523():201-14. PubMed ID: 15088852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.